Connection

Michael Madaio to Abatacept

This is a "connection" page, showing publications Michael Madaio has written about Abatacept.
Connection Strength

0.092
  1. IFN-a confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice. J Immunol. 2011 Aug 01; 187(3):1506-13.
    View in: PubMed
    Score: 0.025
  2. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol. 2008 Feb 01; 180(3):1938-47.
    View in: PubMed
    Score: 0.020
  3. Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus. J Immunol. 2004 Sep 01; 173(5):3524-34.
    View in: PubMed
    Score: 0.016
  4. CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice. Autoimmunity. 2004 Sep-Nov; 37(6-7):445-51.
    View in: PubMed
    Score: 0.016
  5. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol. 2003 Jul 01; 171(1):489-97.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.